Stroke prevention in non-valvular atrial fibrillation: Can warfarin do better?

被引：5

作者：

Apostolakis, Stavros ^{[1
]}

Lip, Gregory Y. H. ^{[1
]}

机构：

[1] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England

来源：

THROMBOSIS AND HAEMOSTASIS | 2011年 / 106卷 / 05期

关键词：

ORAL ANTICOAGULANT; ANTIPLATELET THERAPY; RISK STRATIFICATION; MANAGEMENT; INTENSITY; QUALITY; INR;

D O I：

10.1160/TH11-08-0580

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：753 / 754

页数：2

共 19 条

[1] What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation? [J].

Ahrens, Ingo ;

Lip, Gregory Y. H. ;

Peter, Karlheinz .

THROMBOSIS AND HAEMOSTASIS, 2011, 105 (04) :574-578

[2] New oral anticoagulant drugs in cardiovascular disease [J].

Ahrens, Ingo ;

Lip, Gregory Y. H. ;

Peter, Karlheinz .

THROMBOSIS AND HAEMOSTASIS, 2010, 104 (01) :49-60

[3] Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation" [J].

Apostolakis, Stavros ;

Shantsila, Eduard ;

Lip, Gregory Y. H. ;

Lane, Deirdre A. .

THROMBOSIS AND HAEMOSTASIS, 2009, 102 (05) :914-915

[4] The Quality of Warfarin Prescribing and Monitoring in Veterans Affairs Nursing Homes [J].

Aspinall, Sherrie L. ;

Zhao, Xinhua ;

Handler, Steven M. ;

Stone, Roslyn A. ;

Kosmoski, Janine C. ;

Libby, Elizabeth A. ;

Francis, Susan Dove ;

Goodman, David A. ;

Roman, Rebecca D. ;

Bieber, Heather L. ;

Voisine, Jennifer M. ;

Jeffery, Sean M. ;

Hepfinger, Charley A. ;

Hagen, Diane G. ;

Martin, Micki M. ;

Hanlon, Joseph T. .

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2010, 58 (08) :1475-1480

[5]

Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]

[6] Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range [J].

Connolly, Stuart J. ;

Pogue, Janice ;

Eikelboom, John ;

Flaker, Gregory ;

Commerford, Patrick ;

Franzosi, Maria Grazia ;

Healey, Jeffrey S. ;

Yusuf, Salim .

CIRCULATION, 2008, 118 (20) :2029-2037

[7] Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients [J].

Gallagher, Arlene M. ;

Setakis, Efrosini ;

Plumb, Jonathan M. ;

Clemens, Andreas ;

van Staa, Tjeerd-Pieter .

THROMBOSIS AND HAEMOSTASIS, 2011, 106 (05) :968-977

[8] New-onset atrial fibrillation and warfarin initiation: High risk periods and implications for new antithrombotic drugs [J].

Garcia, David A. ;

Lopes, Renato D. ;

Hylek, Elaine M. .

THROMBOSIS AND HAEMOSTASIS, 2010, 104 (06) :1099-1105

[9] The CHADS2 score for stroke risk stratification in atrial fibrillation - friend or foe? [J].

Karthikeyan, Ganesan ;

Eikelboom, John W. .

THROMBOSIS AND HAEMOSTASIS, 2010, 104 (01) :45-48

[10] Validation of the CHADS2 clinical prediction rule to predict ischaemic stroke A systematic review and meta-analysis [J].

Keogh, Claire ;

Wallace, Emma ;

Dillon, Ciara ;

Dimitrov, Borislav D. ;

Fahey, Tom .

THROMBOSIS AND HAEMOSTASIS, 2011, 106 (03) :528-538

← 1 2 →